Identification of a Novel Protein Phosphatase 2A Activator, PPA24, as a Potential Therapeutic for FOLFOX-Resistant Colorectal Cancer by Hannah Johnson (1342596)

“…<b>PPA24</b> (<b>19a</b>) was identified as the most cytotoxic compound with IC₅₀ values in the range of 2.36–6.75 μM in CRC and FOLFOX-resistant CRC cell lines. …”

Minimal underlying data set. by Machiko K. Asaka (18334223)

Effect of withanone and withaferin A purified from WSWE on <i>S</i>. <i>globosa</i> cells. by Acharya Balkrishna (5640038)

Manuscript data. by Khalid A. Al-Gaadi (2826632)

“…However, the highest mean values of both NDNI (0.232) and GLI (0.386) were observed for salinity-1, indicated healthy condition. …”

Pull down assay of RhoA. by Frank Roloff (695802)

“…Molecular weight of stained protein bands corresponds to about 20 kDa as reported for RhoA. (B) Relative RhoA level was decreased to approximately 50% of control after Ibuprofen treatment whereas RhoA level after LPA treatment was increased to 200% of control. …”

Ibuprofen increased neurite length of human model neurons. by Frank Roloff (695802)

OA-stimulated VSMC proliferation and migration is associated with decreased expression of PGC-1α. by Yan Zhang (8098)

RhoA and Rho kinase inhibitors promote initiation of neurites. by Frank Roloff (695802)

Neonates fail to recover barrier function ex vivo following ischemia due to failure of restitution. by Amanda L. Ziegler (5679557)

“…Note the return of TEER beyond control values in the 30-, 45-, and 60-minute ischemia-injured juvenile mucosa within 120-minutes of <i>ex vivo</i> recovery, while the all ischemia-injured neonatal tissues fail to recover TEER within 120-minutes (n = 5–17, significant interaction between recovery and age on three-way repeated measures ANOVA, P≤0.001). …”

Activating cAMP synthesis decreases liberation of propionyl-CoA from cholesterol. by Kaley M. Wilburn (12060476)

Lipolytic treatment decreased cellular neutral lipids and increased extracellular fatty acids and glycerol. by Caroline Louis (332423)

“…A significant increase of total free FAs and total glycerol was observed over the 12-hour lipolytic treatment (<i>p</i><0.001 for all conditions). Data represent the means of (<i>i</i>) three independent experiments ± SEM for conditions with one PCB congener alone, (<i>ii</i>) five independent experiments ± SEM for conditions with the cocktail of PCBs.…”

Proteomic and Targeted Metabolomic Studies on a Silkworm Model of Parkinson’s Disease by Feifei Zhu (480283)

“…Proteomics analysis revealed a major downregulation of nearly 50 structural proteins constituting cuticles and microfilaments, indicating mechanical damage in the silkworm tissues. …”

Modeling of <i>In-Utero</i> and <i>Intra-Partum</i> Transmissions to Evaluate the Efficacy of Interventions for the Prevention of Perinatal HIV by Patumrat Sripan (741310)

“…<div><p>Background</p><p>Antiretroviral treatments decrease HIV mother-to-child transmission through pre/post exposure prophylaxis and reduction of maternal viral load. …”

S9 Data - by Christoph Anders (4068499)

“…The study was conducted with 25%, 50%, and 75% of the upper body weight. Additionally, we varied the starting point (forward tilt and backward tilt) and the direction of rotation. …”

S11 Data - by Christoph Anders (4068499)

“…The study was conducted with 25%, 50%, and 75% of the upper body weight. Additionally, we varied the starting point (forward tilt and backward tilt) and the direction of rotation. …”

S1 Data - by Christoph Anders (4068499)

“…The study was conducted with 25%, 50%, and 75% of the upper body weight. Additionally, we varied the starting point (forward tilt and backward tilt) and the direction of rotation. …”

S10 Data - by Christoph Anders (4068499)

“…The study was conducted with 25%, 50%, and 75% of the upper body weight. Additionally, we varied the starting point (forward tilt and backward tilt) and the direction of rotation. …”

S6 Data - by Christoph Anders (4068499)

“…The study was conducted with 25%, 50%, and 75% of the upper body weight. Additionally, we varied the starting point (forward tilt and backward tilt) and the direction of rotation. …”

S5 Data - by Christoph Anders (4068499)

“…The study was conducted with 25%, 50%, and 75% of the upper body weight. Additionally, we varied the starting point (forward tilt and backward tilt) and the direction of rotation. …”

S4 Data - by Christoph Anders (4068499)

“…The study was conducted with 25%, 50%, and 75% of the upper body weight. Additionally, we varied the starting point (forward tilt and backward tilt) and the direction of rotation. …”